Published April 17, 2015 | Version v1
Journal article

miR-21 modulates resistance of HR-HPV positive cervical cancer cells to radiation through targeting LATS1

Description

Although multiple miRNAs are found involved in radioresistance development in HR-HPV positive (+) cervical cancer, only limited studies explored the regulative mechanism of the miRNAs. miR-21 is one of the miRNAs significantly upregulated in HR-HPV (+) cervical cancer is also significantly associated with radioresistance. However, the detailed regulative network of miR-21 in radioresistance is still not clear. In this study, we confirmed that miR-21 overexpression was associated with higher level of radioresistance in HR-HPV (+) cervical cancer patients and thus decided to further explore its role. Findings of this study found miR-21 can negatively affect radiosensitivity of HR-HPV (+) cervical cancer cells and decrease radiation induced G2/M block and increase S phase accumulation. By using dual luciferase assay, we verified a binding site between miR-21 and 3′-UTR of large tumor suppressor kinase 1 (LATS1). Through direct binding, miR-21 can regulate LATS1 expression in cervical cancer cells. LATS1 overexpression can reverse miR-21 induced higher colony formation rate and also reduced miR-21 induced S phase accumulation and G2/M phase block reduction under radiation treatment. These results suggested that miR-21-LATS1 axis plays an important role in regulating radiosensitivity. - Highlights: • miR-21 is highly expressed in HR-HPV (+) radioresistant cervical cancer patients. • miR-21 can negatively affect radiosensitivity of HR-HPV (+) cervical cancer cells. • miR-21 can decrease radiation induced G2/M block and increase S phase accumulation. • miR-21 modulates radiosensitivity cervical cancer cell by directly targeting LATS1

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2015.03.004

Additional details

Identifiers

DOI
10.1016/j.bbrc.2015.03.004;
PII
S0006-291X(15)00429-5;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
459
Journal Issue
4
Journal Page Range
p. 679-685
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47031598
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
BUILDUP; COLONY FORMATION; LUCIFERASE; NEOPLASMS; PATIENTS; RADIOSENSITIVITY
Descriptors DEC
DISEASES; ENZYMES; ORGANIC COMPOUNDS; OXIDASES; OXIDOREDUCTASES; PROTEINS; SENSITIVITY

Optional Information

Copyright
Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.